- Home
- ARQT vs ALX Comparison
ARQT vs ALX Comparison
Compare ARQT & ALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | ALX |
|---|---|---|
| Founded | 2016 | 1928 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 1.2B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARQT | ALX |
|---|---|---|
| Price | $29.34 | $217.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $24.83 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 58.1K |
| Earning Date | 10-28-2025 | 02-09-2026 |
| Dividend Yield | N/A | ★ 8.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.14 |
| Revenue | ★ $317,929,000.00 | $215,838,000.00 |
| Revenue This Year | $85.51 | N/A |
| Revenue Next Year | $30.74 | N/A |
| P/E Ratio | ★ N/A | $30.56 |
| Revenue Growth | ★ 129.21 | N/A |
| 52 Week Low | $11.13 | $184.76 |
| 52 Week High | $31.77 | $260.84 |
Technical Indicators
Market Signals| Indicator | ARQT | ALX |
|---|---|---|
| Relative Strength Index (RSI) | 56.62 | 52.03 |
| Support Level | $27.55 | $213.00 |
| Resistance Level | $30.26 | $221.71 |
| Average True Range (ATR) | 1.07 | 4.51 |
| MACD | -0.30 | 0.63 |
| Stochastic Oscillator | 45.09 | 69.25 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.